KRAS-G12D-PROTEINHEMMER

European patent · EP4139299 · In force

Register entry

Publication number
EP4139299
Application number
EP21736393
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 23, 2021
Published
Mar 1, 2023
Granted
Dec 17, 2025
Protection ends at the latest
Apr 22, 2041
Next annual fee due
Apr 30, 2026
IPC classes
C07D 403/12 (2006.01)
C07D 403/14 (2006.01)
A61P 35/00 (2006.01)
A61K 31/551 (2006.01)
Priority
US 202063015132 P 24.04.2020
PCT application
PCT/JP2021/017316 23.04.2021
PCT publication
WO2021/215544 28.10.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 28, 2026

    Change

    Published in Swissreg on 28.10.2026

  2. Dec 17, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 17.12.2025

Parties

Holder

TAIHO PHARMACEUTICAL CO., LTD.

Taiho Pharmaceutical Co., Ltd.

1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444, JP

Inventor

KAWAI, Yuichi

Tsukuba-shi Ibaraki 3002611, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.